1-6 of 6
Steven Knapper, DM BMBCh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegylated-Interferon Treatment Is Safe and Efficient for Pregnant Patients with Essential Thrombocythaemia

Yan Beauverd, Arvind Pillai, MBBS, MRCP, FRCPath, Steven Knapper, DM BMBCh FRCPath MRCP, Catherine Cargo, MB MRCP FRCPath, Claire N. Harrison, Susan Robinson
Journal: Blood
Blood (2015) 126 (23): 1613.
https://doi.org/10.1182/blood.V126.23.1613.1613
Published: 2015
Journal Articles

CD200 and PD1-L1 in AML Are Associated with Expanded PD-1 + Late Differentiated CD8 + T Cells and a Decreased CD4:CD8 Ratio: a New Link Between Distinct Immunosuppressive Pathways

Steven Coles, PhD, Marie N Gilmore, PhD, Reiss Reid, PhD, Steven Knapper, DM BMBCh, Alan K. Burnett, MDFRCP, Steven Man, PhD, Alex Tonks, PhD, Richard L Darley, PhD
Journal: Blood
Blood (2014) 124 (21): 992.
https://doi.org/10.1182/blood.V124.21.992.992
Published: 2014
Journal Articles

A Subpopulation of Blasts with Attenuated p38 MAPK Response Is Seen in Virtually All AML Patients and AML Cell Lines and Is Defined By Cells with Augmented Lipid-Associated Anti-Oxidant Defense

Paul S. Hole, PhD, Sara Davies, MSc, Chinmay R Munje, BSc PhD, Sandra Kreuser, BSc, Robert K. Hills, MA MSc DPhil, Nader Omidvar, PhD, Steven Knapper, DM BMBCh, Alan K. Burnett, MDFRCP, Alex Tonks, BSc PhD, Richard L. Darley, BSc PhD
Journal: Blood
Blood (2014) 124 (21): 785.
https://doi.org/10.1182/blood.V124.21.785.785
Published: 2014
Journal Articles

Pacritinib Suppresses Leukemic Outgrowth from FLT3-ITD Positive Stroma-Adherent Primary AML Cells

Ceri Marrin, MBBCh, Gareth Edwards, PhD, Steven Knapper, DM BMBCh, Alan K. Burnett, MDFRCP, Joanna Zabkiewicz, PhD, Caroline Alvares, MB BS PhD
Journal: Blood
Blood (2014) 124 (21): 270.
https://doi.org/10.1182/blood.V124.21.270.270
Published: 2014
Journal Articles

Integrated Nuclear Proteomics and Transcriptomics Identifies New High Frequency Dysregulated Transcription Factors in AML

Chinmay R Munje, BSc PhD, Andrew J. K. Williamson, BSc, PhD, Samuel Taylor, BSc, PhD, Robert K. Hills, MA, MSc, DPhil, Steven Knapper, DM BMBCh, Alan K. Burnett, MD, Andrew Pierce, BSc, PhD, Anthony Whetton, BSc, PhD, Richard L. Darley, BSc PhD, Alex Tonks, BSc PhD
Journal: Blood
Blood (2014) 124 (21): 3554.
https://doi.org/10.1182/blood.V124.21.3554.3554
Published: 2014
Journal Articles

Response To Ruxolitinib In Patients With Intermediate-1, Intermediate-2 and High-Risk Myelofibrosis: Interim Results Of The UK Robust Trial

Claire N Harrison, DM, FRCP, FRCPath, Richard E Clark, MD, Joseph Chacko, Steven Knapper, DM BMBCh, John Yin, MD, Dragana Milojkovic, PhD, Mira Farquharson, FRCPath, MBChB, MRCP, Sahra Ali, FRCPath, FRCP, BM, MRCP, MRCPath, Mamta K Garg, MD, FRCP, FRCPath, Christopher Andrews, PhD, Cstat, CSci, Susan M Graham, PhD, Adam J. Mead, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 2826.
https://doi.org/10.1182/blood.V122.21.2826.2826
Published: 2013